Considerations in beta-adrenergic blocker evaluation.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001008:Anxiety Disorders / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010200:Panic; D011433:Propranolol / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D011433:Propranolol